B2TK64 AF NFT

Methylglyoxal synthase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeial2t5sagrmltz2jehy5ngeguhwqqcps3w4ubva5d34xukuczj6lq/metadata.json
IPFS of structure file: 
bafybeidsdllldv5px2icyov5zh75aiisymoqs7htvefuoiukcogatz5e7a/AF-B2TK64-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xA4bC8D68d4214ad2dA50789966664825c284F73F
First NFT owner address (bech32): 
genesis15j7g66x5y99d9kjs0zvkvejgyhpgfaelmmk7s8
Current NFT ID #233303 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
233303
Accession (UniProt):
B2TK64
Name::
Methylglyoxal synthase
Experimental Method:
Predicted structure
Sequence source:
Clostridium botulinum (strain Eklund 17B / Type B)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B2TK64 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B2TK64|MGSA_CLOBB Methylglyoxal synthase OS=Clostridium botulinum (strain Eklund 17B / Type B) OX=935198 GN=mgsA PE=3 SV=1 MRIALIAHDKKKQEIIEFAKRNKEALEKYELLATGTTGKMISEETGLNIKRYLSGPYGGDQQIGGRIAEGTIGLVVFFRDPLTAQPHEPDVSALLRVCDVHNIPVVTNSGTADLIIKQF